Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    Virtual Booth

    Contact Supplier

    Menu

    Perselin

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,857Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Approves Henlius and Organon's Bildyos and Bilprevda
    FDA Approves Henlius and Organon's Bildyos and Bilprevda

    02 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-02/us-food-and-drug-administration-fda-approves-henlius-and-organon-s-bildyos-denosumab-nxxp-and-b

    PHARMAWEB
    02 Sep 2025
    Share Share
    Organon Announces Q2 Results Ending June 30, 2025
    Organon Announces Q2 Results Ending June 30, 2025

    05 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250805011781/en/Organon-Reports-Results-for-the-Second-Quarter-Ended-June-30-2025

    BUSINESSWIRE
    05 Aug 2025
    Share Share
    Organon To Report Q2 2025 Results and Host Conference Call
    Organon To Report Q2 2025 Results and Host Conference Call

    22 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250722000126/en/Organon-To-Report-Second-Quarter-2025-Results-and-Host-Conference-Call-on-August-5-2025

    BUSINESSWIRE
    22 Jul 2025
    Share Share
    VTAMA® Cream Earns Top Spot in 2025 Derm Guidelines
    VTAMA® Cream Earns Top Spot in 2025 Derm Guidelines

    07 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250707974353/en/Organons-VTAMA-tapinarof-cream-1-Granted-Strong-Recommendation-in-the-American-Academy-of-Dermatology-Updated-2025-Guidelines-for-Adult-Atopic-Dermatitis

    BUSINESSWIRE
    07 Jul 2025
    Share Share
    Organon Updates Ph2 OG-6219 Data in Endometriosis Pain
    Organon Updates Ph2 OG-6219 Data in Endometriosis Pain

    02 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250702870387/en/Organon-Provides-Update-on-Phase-2-ELENA-Proof-of-Concept-Study-Evaluating-OG-6219-in-Patients-with-Endometriosis-Related-Pain

    BUSINESSWIRE
    02 Jul 2025
    Share Share
    FDA Grants interchangeability to Samsung & Organon Hadlima Inj
    FDA Grants interchangeability to Samsung & Organon Hadlima Inj

    27 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250527970852/en/US-Food-and-Drug-Administration-FDA-Grants-Interchangeability-Designation-to-Samsung-Bioepis-and-Organon-HADLIMA-adalimumab-bwwd-Injection

    BUSINESSWIRE
    27 May 2025
    Share Share